[go: up one dir, main page]

AR088600A1 - Composiciones de yodo-povidona - Google Patents

Composiciones de yodo-povidona

Info

Publication number
AR088600A1
AR088600A1 ARP120104081A ARP120104081A AR088600A1 AR 088600 A1 AR088600 A1 AR 088600A1 AR P120104081 A ARP120104081 A AR P120104081A AR P120104081 A ARP120104081 A AR P120104081A AR 088600 A1 AR088600 A1 AR 088600A1
Authority
AR
Argentina
Prior art keywords
percent
weight
composition
hydrogenated
iodine
Prior art date
Application number
ARP120104081A
Other languages
English (en)
Inventor
Lentini Peter
Original Assignee
Microdermis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48192689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR088600(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Microdermis Corp filed Critical Microdermis Corp
Publication of AR088600A1 publication Critical patent/AR088600A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Detergent Compositions (AREA)

Abstract

Una composición que incluye entre 4 por ciento en peso y 12 por ciento en peso de un complejo povidona-yodo, entre 0,1 por ciento en peso y 2 por ciento en peso de una amida terciaria, sal de amida terciaria, y/o hidrato de amida terciaria, entre 0,5 por ciento en peso y 2 por ciento en peso de un emoliente con baja reactividad al yodo, al menos un tensioactivo, y agua. La composición tiene un pH entre 2,0 y 3,5. Reivindicación 8: La composición de la reivindicación 1, caracterizada porque el emoliente con baja reactividad al yodo se selecciona entre los grupos que consisten en aceite de jojoba, ésteres de aceite de jojoba hidrogenado, polibutenos hidrogenados, isododecano, tribehenato de glicerilo, aceite de ricino hidrogenado, aceite de palma, derivados de los mismos y combinaciones de los mismos.
ARP120104081A 2011-10-31 2012-10-31 Composiciones de yodo-povidona AR088600A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161553503P 2011-10-31 2011-10-31

Publications (1)

Publication Number Publication Date
AR088600A1 true AR088600A1 (es) 2014-06-18

Family

ID=48192689

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104081A AR088600A1 (es) 2011-10-31 2012-10-31 Composiciones de yodo-povidona

Country Status (11)

Country Link
US (3) US20130121953A1 (es)
EP (1) EP2773201B1 (es)
AR (1) AR088600A1 (es)
BR (1) BR112014010564A2 (es)
CL (1) CL2014001112A1 (es)
CO (1) CO7010827A2 (es)
CR (1) CR20140186A (es)
EC (1) ECSP14002959A (es)
HK (1) HK1201687A1 (es)
PE (1) PE20141580A1 (es)
WO (1) WO2013066909A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012135055A2 (en) * 2011-03-25 2012-10-04 Delaval Holding Ab Low surfactant iodine topical disinfectant
US20160366879A1 (en) 2015-06-22 2016-12-22 Infection Containment Company, LLC Topical antiseptic system
CN113318122B (zh) * 2021-03-24 2022-06-24 厦门大开生物科技有限公司 一种含有聚维酮碘的消毒剂组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716611A (en) * 1996-01-02 1998-02-10 Euro-Celtique, S.A. Emollient antimicrobial formulations containing povidone iodine
US6436379B1 (en) * 1997-10-17 2002-08-20 International Flora Technologies Ltd. Emollient for cuticle treatment and delivery system therefore
US6559182B1 (en) * 2001-11-07 2003-05-06 Purcell Jojoba International, Llc Method for treatment of enveloped viruses using jojoba oil esters
WO2004026259A2 (en) * 2002-09-20 2004-04-01 Griscom Bettle, Iii Transdermal compositions
EP2566488B1 (en) * 2010-05-07 2016-07-13 Microdermis Corporation Povidone-iodine topical composition

Also Published As

Publication number Publication date
US20130121953A1 (en) 2013-05-16
EP2773201B1 (en) 2017-12-06
HK1201687A1 (en) 2015-09-11
ECSP14002959A (es) 2017-05-31
EP2773201A1 (en) 2014-09-10
EP2773201A4 (en) 2015-05-20
US20190117783A1 (en) 2019-04-25
PE20141580A1 (es) 2014-11-20
BR112014010564A2 (pt) 2017-04-25
CR20140186A (es) 2014-08-28
CL2014001112A1 (es) 2014-07-11
WO2013066909A1 (en) 2013-05-10
CO7010827A2 (es) 2014-07-31
US20180243424A1 (en) 2018-08-30

Similar Documents

Publication Publication Date Title
MX2018003775A (es) Composiciones para el cuidado bucal y metodos de uso.
UA113165C2 (xx) Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
BR112015022782A2 (pt) composto, composição farmacêutica, combinação, e, uso de um composto
AR089274A1 (es) Composicion de grasa
AR089269A1 (es) Composiciones para el cuidado oral
BR112014009031A2 (pt) formulações de etanercept estabilizadas com íons de metais
AR082252A1 (es) Composiciones farmaceuticas moduladoras de c-met
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
MX2015011054A (es) Composicion de glifosato para mezclas de tanque con dicamba con volatilidad mejorada.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
AR082422A1 (es) Composicion detergente liquida
AR081819A1 (es) Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades
AR091039A1 (es) Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento
EA201591067A1 (ru) Неводные композиции для ухода за полостью рта
MX2019004579A (es) Composiciones para el cuidado bucal y metodos de uso.
CO6400226A2 (es) Micrólido anti-inflamatorio
CL2012003282A1 (es) Composicion farmaceutica topica que comprende, en base al peso total de la composicion a) 0,01 a 0,2% en peso de furoato de mometasona, b) 5 a 18% en peso de hexilenglicol, c) 20 a 40% en peso de agua y d) 25 a 70% en peso de una fase oleosa; y su uso para tratar o prevenir psoriasis, dermatitis atopica, entre otros.
AR087371A1 (es) Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos
AR088600A1 (es) Composiciones de yodo-povidona
PE20100154A1 (es) Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c, asi como preparados farmaceuticos que las contienen
AR093717A1 (es) Composiciones y metodos para el tratamiento de la caries dental
EA201490881A1 (ru) Органогель, структурированный 12-hsa и выбранным сополимером
BR112014030992A2 (pt) composições compreendendo calcogenetos e métodos relacionados
MX2017007856A (es) Composicion para el cuidado bucal.
UY30482A1 (es) Sulfoximinas sustituidas como inhibidores de tie2 y sus sales, composiciones farmaceuticas que comprenden las mismas, metodos para prepararlas y sus usos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure